...
首页> 外文期刊>Genetic testing and molecular biomarkers >Molecular Study of the PCA3 Gene: Genotypic Analysis of PCA3 Polymorphism -845G A and Metastatic Prostate Cancer
【24h】

Molecular Study of the PCA3 Gene: Genotypic Analysis of PCA3 Polymorphism -845G A and Metastatic Prostate Cancer

机译:分子研究PCA3基因:基因型分析PCA3多态性-845 g A和转移性前列腺癌

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: The prostate cancer gene 3 (PCA3) is a prostate-specific, non–protein-coding RNA. It is overexpressed in prostate cancer compared with the normal prostate and has a negative expression in other tissues. This case– control study sought to analyze the frequency of the polymorphism PCA3 -845 G>A in participants without prostate cancer and patients with metastatic prostate cancer. Results: Carriers of GA and AA genotype had a higher risk for metastatic prostate cancer (odds ratio [OR] for genotype GA, 1.79 [95% confidence interval (CI), 1.14–2.29]; p = 0.007; OR for genotype AA, 2.38 [95% CI, 1.22–4.65]; p = 0.006). Furthermore, the recessive model showed that A allele carriers have an increased risk for developing metastatic prostate cancer (OR, 1.91 [95% CI, 1.26–2.90]; p = 0.001). Conclusions: These results suggest a link between PCA3 and metastatic prostate cancer. The evaluation of individual genetic profiles, according to the PCA3 -845 G>A polymorphism, may elucidate the function of this gene and the mechanisms involved in its regulation and role in prostate cancer.
机译:目的:前列腺癌基因3 (PCA3)前列腺特异性,non-protein-coding RNA。在前列腺癌相比正常的前列腺癌和消极的表达在其他组织。分析多态性PCA3的频率-845 G > A参与者没有前列腺癌和转移性前列腺癌患者。结果:运营商的GA和AA基因型转移性前列腺癌的风险更高(赔率基因型遗传算法比[或],1.79[95%的信心时间间隔(CI), 1.14 - -2.29);基因型AA, 2.38(95%可信区间,1.22 - -4.65);0.006)。一个等位基因携带者的风险增加发展中转移性前列腺癌(或者1.91(95% CI, 1.26 - -2.90);这些结果表明PCA3和之间的联系转移性前列腺癌。个人遗传图谱,根据PCA3 -845 G > A多态性,可以阐明这个基因的功能及其机制在其监管和前列腺癌的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号